Retatrutide

Retatrutide is an investigational peptide that acts as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously. Originally developed for metabolic research, it has shown remarkable results in studies related to weight reduction, energy expenditure, and glucose regulation. As a research compound, Retatutide is used strictly for scientific and laboratory purposes.

All our peptides are synthesized using high-performance liquid chromatography (HPLC) purification and undergo rigorous third-party testing for purity, potency, and sterility. Every batch is accompanied by a Certificate of Analysis (COA) from an independent, accredited laboratory. We source only from GMP-compliant manufacturers to guarantee the highest research-grade standards.

Research studies on Retatrutide have demonstrated significant potential in metabolic regulation. Key areas of scientific interest include substantial reduction in body weight, improved insulin sensitivity, enhanced energy expenditure through glucagon receptor activation, and favorable effects on lipid profiles. Its triple-agonist mechanism makes it one of the most studied peptides in current obesity and metabolic disorder research.

Each order includes a lyophilized Retatrutide vial in your selected dosage (10mg, 15mg, or 20mg), a product information card, and a downloadable Certificate of Analysis (COA). Bacteriostatic water and reconstitution supplies are sold separately.